BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 6981365)

  • 1. Clinical significance of screening for antibody to ribonucleoprotein.
    Small P; Barrett D; Champlin E
    Ann Allergy; 1982 Sep; 49(3):152-5. PubMed ID: 6981365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of antibodies to ribonucleoprotein and Sm antigens with mixed connective-tissue disease, systematic lupus erythematosus and other rheumatic diseases.
    Sharp GC; Irvin WS; May CM; Holman HR; McDuffie FC; Hess EV; Schmid FR
    N Engl J Med; 1976 Nov; 295(21):1149-54. PubMed ID: 1086429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies to components of extractable nuclear antigen. Clinical characteristics of patients.
    Farber SJ; Bole GG
    Arch Intern Med; 1976 Apr; 136(4):425-31. PubMed ID: 1083722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serial estimation of anti-RNP antibody titers in systemic lupus erythematosus, mixed connective tissue disease and rheumatoid arthritis.
    Nishikai M; Okano Y; Mukohda Y; Sato A; Ito M
    J Clin Lab Immunol; 1984 Jan; 13(1):15-9. PubMed ID: 6609234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of anti-ENA, Sm and RNP antibodies in patients with antinuclear antibodies.
    Levo Y; Lotan C
    Isr J Med Sci; 1982 Feb; 18(2):287-9. PubMed ID: 6978327
    [No Abstract]   [Full Text] [Related]  

  • 6. Patterns of clinical disease associated with antibodies to nuclear ribonucleoprotein.
    Maddison PJ; Mogavero H; Reichlin M
    J Rheumatol; 1978; 5(4):407-11. PubMed ID: 310884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Mixed connective tissue disease, a clinical syndrome with anti-ribonucleoprotein antibodies].
    Elling H
    Ugeskr Laeger; 1978 Dec; 140(50):3140-2. PubMed ID: 310186
    [No Abstract]   [Full Text] [Related]  

  • 8. Antiribonucleoprotein antibodies in connective tissue diseases: estimation by counterimmunoelectrophoresis.
    Bresnihan B; Bunn C; Snaith ML; Hughes GR
    Br Med J; 1977 Mar; 1(6061):610-1. PubMed ID: 843832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Joint lesions and antibodies to ribonucleoproteins in mixed connective tissue disease].
    Del'barr F; Del'r'e F
    Ter Arkh; 1980; 52(6):62-4. PubMed ID: 6967634
    [No Abstract]   [Full Text] [Related]  

  • 10. Free serum ribonucleoprotein in mixed connective tissue disease and other connective tissue diseases.
    Fishbein E; Ramos-Niembro F; Alarcon-Segovia D
    J Rheumatol; 1978; 5(4):384-90. PubMed ID: 310882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mixed connective tissue disease.
    Prystowsky SD
    West J Med; 1980 Apr; 132(4):288-93. PubMed ID: 7385833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of antibodies to ribonucleoprotein.
    Cohen ML; Dawkins B; Dawkins RL; Owen ET
    Ann Rheum Dis; 1979 Feb; 38(1):74-8. PubMed ID: 312058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical characteristics and course in patients with high titer anti-RNP antibodies.
    Lemmer JP; Curry NH; Mallory JH; Waller MV
    J Rheumatol; 1982; 9(4):536-42. PubMed ID: 6982334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mixed connective tissue disease in childhood. A clinical and serologic survey.
    Singsen BH; Bernstein BH; Kornreich HK; King KK; Hanson V; Tan EM
    J Pediatr; 1977 Jun; 90(6):893-900. PubMed ID: 300795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibodies against distinct nuclear matrix proteins are characteristic for mixed connective tissue disease.
    Habets WJ; de Rooij DJ; Salden MH; Verhagen AP; van Eekelen CA; van de Putte LB; van Venrooij WJ
    Clin Exp Immunol; 1983 Oct; 54(1):265-76. PubMed ID: 6352106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Collagen-vascular diseases.
    Rothschild B
    Prim Care; 1984 Jun; 11(2):307-23. PubMed ID: 6566363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical characteristics of patients with nuclear antiribonucleoprotein antibodies. Evidence of circulating immunocomplexes in mixed connective tissue disease].
    Rodríguez-Valverde V; Orte Martínez J; Sampedro Alvarez J; Peña Sagredo JL; Sánchez Andrada S
    Med Clin (Barc); 1982 Jun; 79(1):9-15. PubMed ID: 7121111
    [No Abstract]   [Full Text] [Related]  

  • 18. Problems in differentiating SLE and mixed connective-tissue disease.
    Reichlin M
    N Engl J Med; 1976 Nov; 295(21):1194-5. PubMed ID: 1086430
    [No Abstract]   [Full Text] [Related]  

  • 19. Frequency and clinical significance of antibodies to ribonucleoprotein in SLE and other connective tissue disease subgroups.
    Grennan DM; Bunn C; Hughes GR; Buchanan WW; Dick WC
    Ann Rheum Dis; 1977 Oct; 36(5):442-7. PubMed ID: 921344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibodies against extractable nuclear antigens (ENA) in systemic scleroderma.
    Jabłońska S; Błaszczyk M; Górkiewicz A; Jarzabek-Chorzelska M; Rzesa G; Chorzelski T
    Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):765-8. PubMed ID: 312085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.